HIGHLIGHTS
- What: The authors explored the possibility that serum levels of hepcidin could help predict the prognosis of mCRC.
- Who: Vincenzo Formica and colleagues from the Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy have published the paper: Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line Treatment, in the Journal: Cancers 2024, 3977 of /2024/
- How: The controls of this study were slightly younger than the mCRC patients but it is unlikely that this could have influenced the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.